Jun 02, 2020
WAKIX® (pitolisant) Data From Harmony Biosciences Included on American Academy of Neurology Science Highlights Virtual Platform
May 15, 2020
Sleep Aids Market Worth $114.15 Billion by 2025: Exclusive Report by Infinium Global Research
May 12, 2020
Narcolepsy Market Analysis 2016-2024: Pipeline, Epidemiology, Competitive Analysis, Drug Sales and Shares
Apr 27, 2020
Harmony Biosciences Expands Patients At The Heart Grant Program And Reinforces Its Commitment To Newly Uninsured Patients
Mar 30, 2020
Harmony Biosciences Highlights Publication Of Narcolepsy Treatment Scientific Review In Sleep Medicine
Mar 25, 2020
Jazz Pharmaceuticals Announces FDA Acceptance of New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy
Jan 22, 2020
Jazz Pharmaceuticals Submits New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy
Jan 13, 2020
Sosei Heptares: Significant Progress by Orexia and Inexia With Orexin Agonist Program Triggers Next Tranche of Funding From Medicxi
Dec 27, 2019
Pivotal Phase 3 Study of DAYVIGO(TM) (lemborexant) for the Treatment of Insomnia Disorder Published in JAMA Network Open
Dec 23, 2019
U.S. FDA Approves Eisai's DAYVIGO(TM) (lemborexant) for the Treatment of Insomnia in Adult Patients
Nov 19, 2019
Project Sleep Partners with Sleep Research Society to Host Third Annual Advocacy Day
Nov 15, 2019
Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea
Sep 25, 2019
Jazz Pharmaceuticals Presents Positive JZP-258 Phase 3 Study Data at World Sleep 2019
Sep 20, 2019
Harmony Biosciences Announces Recipients of 2019 Patients at the Heart Grant in Recognition of World Narcolepsy Day
Sep 16, 2019
Harmony Biosciences To Present Clinical Data On WAKIX® (pitolisant) At Upcoming World Sleep 2019
Aug 19, 2019
Narcolepsy Network Partners with Patient Advocacy Organizations to Celebrate Global Narcolepsy Awareness Day
Jul 16, 2019
Narcolepsy Drugs Market to Garner $5.36 Bn, Globally, by 2026 at 10.3% CAGR: Says Allied Market Research
Jun 26, 2019
Global narcolepsy treatment market is expected to grow with a CAGR of 7.8% over the forecast period from 2019-2025
Jun 24, 2019
FDA Grants Orphan Drug Designation to XW Laboratories' XWL-008 for the Treatment of Patients with Narcolepsy
Jun 04, 2019
Harmony Biosciences To Present New Data On Pitolisant In Patients With Narcolepsy At SLEEP 2019 Meeting